Business Wire

Snow Software Surpasses $100 Million in Annual Recurring Revenue

Share

Snow Software, the global leader in technology intelligence, today announced it surpassed $100 million in annual recurring revenue (ARR). Fueled by skyrocketing cloud adoption, increasing security threats and the need to optimize IT budgets, Snow started the year with 40% year-over-year growth in total ACV bookings driven by 115% growth in subscription ACV bookings. These milestones were achieved as Snow successfully pivoted to a recurring revenue business model, now at 75% recurring revenue and growing, and remains on track to positive EBITDA in 2020.

“As organizations accelerate their reliance on cloud, complex hybrid environments are the new reality for many IT leaders, and Snow sits at the nexus of this transformation,” said Vishal Rao, President and Chief Executive Officer at Snow. “Crossing $100 million ARR reaffirms that visibility, optimization and governance across all technology is a strategic priority for the enterprise. Of course, we would not have been able to achieve this milestone without the continuous support of our customers and partners. Today, we serve Global 2000 companies in healthcare, finance, energy, defense and more – the trust that organizations like NASA, Nordstrom, ING, Dyson and Vodafone have placed in us is humbling. By providing a flexible platform of best-in-class solutions for managing software, SaaS, hardware and cloud, we are uniquely positioned to deliver long-term value for the world’s largest organizations.”

Snow has continued to double down on innovation to address the growing market need for asset management, cost optimization and risk mitigation both on-premises and in the cloud. Over the past year, Snow has deepened its SaaS capabilities to include advanced functionality for essential workplace tools such as Office 365 and Adobe Creative Suite as well as remote work staples such as Zoom, GoToMeeting and WebEx, driving its SaaS product to 500% year-over-year ACV bookings growth. Snow also acquired the leading hybrid cloud management company Embotics, and has seen strong demand for its award-winning Commander cloud management platform from both prospects and existing customers.

“Now, more than ever, it’s essential that companies optimize IT spend, minimize risks and increase governance over technology investments,” said Mike Risman, Chairman of the Board at Snow and Managing Partner at Vitruvian. “When we first invested in Snow, they were the dominant players in the European market with a strong focus on software asset management. Over the past two years, they have truly transformed the business to meet the needs of today’s IT leaders. Snow has now achieved global scale as a platform player with unmatched breadth and depth. We are thrilled to continue working with the team as they deliver on Snow’s bold vision for technology intelligence.”

Analysts and industry experts continue to recognize Snow. In 2020, Snow was named a Leader in the Gartner Magic Quadrant for Cloud Management Platforms1 for the second year in a row. Snow was also a finalist in both the ITAM Review Excellence Awards and SIIA CODIE Awards. This follows a strong 2019, where Snow was recognized as a Leader in the Gartner Magic Quadrant for Software Asset Management Tools2 for the second year in a row. In addition to analyst and industry recognition, Snow was named a 2019 Gartner Peer Insights Customers’ Choice in Software Asset Management Tools for the third time.

1 Gartner, “Magic Quadrant for Cloud Management Platforms” by Dennis Smith, Sanjit Ganguli, Padraig Byrne. February 13, 2020. Snow was positioned as Snow Software-Embotics.
2 Gartner, “Magic Quadrant for Software Asset Management Tools” by Roger Williams, Matt Corsi, Ryan Stefani, April 24, 2019.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Gartner Peer Insights Customers’ Choice constitute the subjective opinions of individual end-user reviews, ratings, and data applied against a documented methodology; they neither represent the views of, nor constitute an endorsement by, Gartner or its affiliates.

About Snow Software

Snow Software is the global leader in technology intelligence solutions, ensuring the trillions spent on all forms of technology is optimized to drive maximum value. More than 4,000 organizations around the world rely on Snow's platform to provide complete visibility, optimize usage and spend, and minimize regulatory risk. Headquartered in Stockholm, Snow has more local offices and regional support centers than any other software asset and cloud management provider, delivering unparalleled results to our customers and partners. To find out more about Snow Software, visit www.snowsoftware.com.

For the latest information about Snow, please visit:

Web:www.snowsoftware.com
Twitter: @snowsoftware

Contact information

Julie Neumann
Snow Software
julie.neumann@snowsoftware.com
+1 615 498 9650

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Xerox Launches ConnectKey-Enabled AltaLink Digital Workplace Assistant15.7.2020 18:47:00 CESTPress release

Xerox announced its new https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.office.xerox.com%2Fen-us%2Fmultifunction-printers%2Faltalink-c8100-series&esheet=52250531&newsitemid=20200715005746&lan=en-US&anchor=Xerox+AltaLink%26%23174%3B+C8100&index=1&md5=59e47e2191588f21b4da900931086697 Xerox AltaLink® C8100 and Xerox AltaLink B8100 Series multi-function printers (MFPs), that can better support today’s flexible work environment and help companies speed their digital transformation with access to the ConnectKey® ecosystem of apps. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200715005746/en/ The tablet-like user interface allows for easy, familiar interaction or the user can choose to print from their mobile devices. (Photo: Business Wire) In addition to its printing capabilities, the AltaLink 8100 series helps speed workplace digitization with ultra-fast scanning of up to 270 images per minute and Optical

Bureau Veritas Launches a New Solution to Improve Supply Chain Resilience15.7.2020 17:45:00 CESTPress release

Bureau Veritas, a world leader in testing, inspection and certification (TIC) services, is launching Supply-R, a solution designed to meet companies’ new challenges relating to supplier network reliability and ensuring business continuity in all circumstances. Organizations learned multiple lessons during the first half of 2020 on the resilience of global supply chains and their ability to face disruptions. There is an urgent need from many companies to reassess their supply chain risk, based on factual data from the field, to make sure that all elements are properly addressed, assessed and visible. Bruno Ferreyra, Executive Vice-President at Bureau Veritas, commented: "Economic globalization means supply chains include more suppliers and intermediaries than before, and they are scattered around the globe. This makes each step, process and stakeholder in the manufacturing chain harder to track. Our goal is to support businesses, mapping out their supply chains to give them complete con

VALBIOTIS Announces the First Patient First Visit in the International Phase II/III REVERSE-IT Clinical Study on TOTUM-63 to Reduce Type 2 Diabetes Risk Factors15.7.2020 17:40:00 CESTPress release

Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 - ALVAL, PEA/SME eligible) a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the First Patient First Visit in the international Phase II/III REVERSE-IT clinical study designed to assess TOTUM-63 for the reduction of Type 2 Diabetes metabolic risk factors. Murielle CAZAUBIEL, member of the Management Board and Director of Development and Medical Affairs at VALBIOTIS, comments: "The first visit of this first subject, a few days after obtaining both ANSM1 approval and the favorable decision from the CPP2, marks the concrete launch of the REVERSE-IT study, the results of which are expected in mid-2022. We are right on schedule and are delighted to be able to enter the operational phase of this major study so quickly. We also welcome the enthusiasm and commitment of all the partner investigation centers." Dr Hans-Juergen WOERLE, Chief Scientific and Medical Off

Octapharma Reports Positive Data from octagam ® Usage in Critically Ill COVID-19 Patients15.7.2020 17:04:00 CESTPress release

Topline results from a retrospective study in 93 critically ill COVID-19 patients have become available. The data shows that IVIG treatment reduces inflammation, which is associated with poor clinical outcomes and death, and points to an increase in survival, in critically ill COVID-19 patients, when compared to a control group. The study was conducted at the Istanbul University Hospital, Turkey, under the lead of Prof. Dr. Figen Esen. In critically ill COVID-19 patients, the cause of death often implicates an abnormal pulmonary immune response. This abnormal immune response is characterized by high levels of inflammatory markers, which are associated with poor clinical outcomes.1, 2 Acute respiratory distress syndrome (ARDS) and multiorgan failure are major causes of mortality in COVID-19 patients.3 High levels of pro-inflammatory cytokines and chemokines are part of a severe inflammatory response known as a “cytokine storm” which may cause multiple organ dysfunction and ARDS in criti

European Commission approves third nintedanib indication in pulmonary fibrosis 115.7.2020 15:34:00 CESTPress release

Boehringer Ingelheim today announced that the European Commission (EC) has approved an additional indication for nintedanib in adults for the treatment of other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype beyond idiopathic pulmonary fibrosis (IPF).1 The approval comes after the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion in May 2020.3 The U.S. Food and Drug Administration (FDA), Health Canada and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) recently approved nintedanib as the first treatment for the same patient population.4,5,6 Interstitial lung diseases encompass a large group of more than 200 disorders that may involve the threat of pulmonary fibrosis – an irreversible scarring of lung tissue that negatively impacts lung function.7 People living with fibrosing ILD can develop a progressive phenotype, leading to lung function decline, deterioration in quality of life and early mortality simila

With U.S. Cotton Trust Protocol, Brands and Retailers Can Now Source U.S. Cotton with More Confidence15.7.2020 15:05:00 CESTPress release

Startingtoday, brands and retailers can join the U.S. Cotton Trust Protocol, a new system for responsibly grown cotton that will provide annual data for six areas of sustainability in line with the U.N. Sustainability Goals. This year-over-year data, available for the first time, will allow brands and retailers to better measure progress towards meeting sustainability commitments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200715005278/en/ (Graphic: Business Wire) “One of our goals in developing the Trust Protocol is to give brands and retailers greater confidence when including U.S. cotton in their sourcing mix,” said Ken Burton, Executive Director of the U.S. Cotton Trust Protocol. “Participating brands and retailers will now be able to demonstrate measurable progress in reducing their environmental footprint and in achieving sustainability targets.” The Trust Protocol underpins and verifies sustainability progress thr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom